[Federal Register Volume 62, Number 57 (Tuesday, March 25, 1997)]
[Notices]
[Pages 14158-14159]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-7374]


-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institute of Child Health and Human Development; Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
National Institute of Child Health and Human Development Special 
Emphasis Panel (SEP) meeting:

    Name of SEP: Use of Genetically Modified Skin to Treat Disease.
    Date: April 9-10, 1997.
    Time: April 9--7 p.m.--9 p.m.; April 10--8:30 a.m.--adjournment.
    Place: Quality Inn Hotel, 154 West 600 Street, Salt Lake City, 
Utah 84132.
    Contact Person: Gopal Bhatnagar, Ph.D., Scientific Review 
Administrator, NICHD, 6100 Executive Boulevard, 6100 Building, Room 
5E01, Rockville, Maryland 20852, Telephone: 301-496-1485.
    Purpose/Agenda: To evaluate and review grant applications.
    The meeting will be closed in accordance with the provisions set 
forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. The 
discussions of this application could reveal confidential trade 
secrets or commercial property such as patentable material and 
personal information concerning individuals associated with the 
applications, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance Program Nos. [93.864, 
Population Research and No. 93.865, Research for Mothers and 
Children, National Institutes of Health)


[[Page 14159]]


    Dated: March 19, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, National Institutes of Health.
[FR Doc. 97-7374 Filed 3-24-97; 8:45 am]
BILLING CODE 4140-01-M